JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Epithalon is a tetrapeptide research compound (Ala-Glu-Asp-Gly) extensively studied in cell-based assay formats for its telomerase activation properties and interactions with telomere maintenance pathways. Published in vitro research demonstrates its capacity to modulate telomerase reverse transcriptase (TERT) activity through the telomeric repeat amplification protocol (TRAP) assay, characterizing telomere length dynamics and pineal gland pathway interactions. Laboratory investigations focus on molecular interactions, binding affinity profiles, and downstream signaling cascade engagement in defined cell model systems under controlled experimental conditions.
Epithalon demonstrates primary activity through telomerase enzyme complex modulation, specifically targeting the catalytic subunit TERT and the RNA component TERC. In vitro TRAP assays reveal concentration-dependent activation of telomerase enzymatic activity across multiple cell line models. The peptide exhibits binding interactions with regulatory elements upstream of the TERT promoter region, influencing transcriptional activation through chromatin remodeling mechanisms.
Research utilizing quantitative polymerase chain reaction (qPCR) methodologies demonstrates epithalon's capacity to upregulate TERT mRNA expression in primary cell cultures. Dose-response curves establish EC50 values ranging from 0.1-1.0 μM depending on cell type specificity, with maximal activation occurring at concentrations between 5-10 μM in standard experimental protocols.
Cell-based assays utilizing pinealocyte model systems reveal epithalon's modulatory effects on melatonin synthesis pathways. The peptide demonstrates binding affinity for arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme in melatonin biosynthesis. Enzyme kinetics studies indicate competitive inhibition patterns with Km values of approximately 2.3 μM for AANAT substrate interactions.
Fluorescence polarization assays confirm direct binding interactions between epithalon and pineal regulatory proteins, establishing KD values in the nanomolar range for high-affinity binding sites. These interactions correlate with downstream modulation of cyclic adenosine monophosphate (cAMP) signaling cascades and protein kinase A (PKA) activation states.
Human diploid fibroblast cultures serve as standard model systems for epithalon telomerase research. These primary cell lines demonstrate reproducible responses to peptide treatment, with telomerase activity measurements conducted through standardized TRAP protocols. Cell passage number correlations reveal inverse relationships between baseline telomerase activity and peptide responsiveness, establishing optimal experimental windows for consistent results.
Immortalized cell lines including HeLa, MCF-7, and HEK293 provide complementary model systems for mechanistic investigations. Each cell type exhibits distinct baseline telomerase expression profiles, enabling comparative pharmacological characterization across different cellular contexts.
Terminal restriction fragment (TRF) analysis protocols enable direct measurement of telomere length changes following epithalon treatment. Quantitative fluorescence in situ hybridization (Q-FISH) techniques provide single-cell resolution for telomere dynamics assessment, revealing heterogeneous responses within cell populations.
Flow cytometry-based telomere length assays (Flow-FISH) facilitate high-throughput screening applications, generating statistically robust datasets for concentration-response relationship establishment. These methodologies consistently demonstrate telomere length preservation in epithalon-treated cell cultures compared to control conditions.
Chromatin immunoprecipitation (ChIP) assays reveal epithalon's influence on transcription factor binding at the TERT promoter locus. The peptide enhances c-Myc and Sp1 recruitment while reducing p53 and Rb protein association, creating a transcriptionally permissive chromatin environment for telomerase expression.
Luciferase reporter assays utilizing TERT promoter constructs demonstrate concentration-dependent transcriptional activation, with maximal induction achieving 3-5 fold increases over baseline expression levels. Site-directed mutagenesis studies confirm the requirement for intact E-box and GC-box elements for epithalon-mediated activation.
Phosphoproteomic analyses identify multiple phosphorylation sites within the TERT protein that undergo modification following epithalon treatment. Mass spectrometry-based approaches reveal enhanced phosphorylation at serine residues 227 and 824, correlating with increased enzymatic activity and nuclear localization efficiency.
Epithalon demonstrates significant potential as a research tool for investigating telomerase biology and cellular aging mechanisms. In vitro studies establish clear concentration-response relationships for telomerase activation, with optimal activity occurring in the micromolar concentration range. The peptide's dual functionality in both telomerase pathway modulation and pineal gland signaling regulation provides unique opportunities for multi-pathway research applications. Standardized assay protocols enable reproducible experimental outcomes across diverse cell model systems, supporting continued investigation into telomere maintenance mechanisms and their role in cellular longevity research.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.